WNT5A and asthma: Therefore, we have generated a tetracycline-based (tet-ON) smooth-muscle-specific WNT5A transgenic mouse model, enabling in vivo characterization of the relevance of smooth-muscle derived WNT5A in an allergic asthmatic context, using chronic ovalbumin exposure to drive asthma-like changes.